Education Events

On 22 July, most of the authorship group of COGNO’s Expert Position Statement on the management of adults with IDH-mutant gliomas will come together for a two-hour case-based webinar, working through three clinical scenarios spanning grade 2 to grade 4 disease. The cases cover the questions that generate the most debate in practice: when to treat versus watch, the role of vorasidenib after resection, PCV versus temozolomide in oligodendroglioma, and the Stupp versus CATNON approach in grade 4 astrocytoma. Emerging trials including VIGOR, SIGMA, and LUMOS-2 will also be discussed.

Brought to you by the COGNO Education Committee. ‘From Idea to Trial Concept’ is the first in a new series of COGNO skills development workshops, designed to build research capacity across the neuro-oncology community. This half-day workshop is aimed at those who are interested in developing a neuro-oncology clinical trial but are at the early stages of that journey. The session will take participants through the process of moving from an initial idea to a coherent, well-framed trial concept.

Join us for an exclusive virtual recap of the latest breakthroughs in brain cancer research and treatment emerging presented at the 7th World Federation of Neuro-Oncology Societies (WFNOS) and 30th Society for Neuro-Oncology(SNO) Meetings in Honolulu, Hawaii. This webinar will highlight the most impactful updates with a focus on clinical relevance and research trends. Speakers attending the event and expert panel will explore the latest findings with an Australian lens. Stay tuned for the video recording, available to all COGNO members.

Hosted by the COGNO Outreach and Education Committee, this session will highlight the most impactful updates with a focus on clinical relevance and research trends. Our expert panel discussion will explore how the new international data impacts patient care at home. Join us for a focused webinar exploring the latest developments in brain cancer research and treatment, presented at one of the most influential oncology conferences — the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting. This session will highlight the most impactful updates with a focus on clinical relevance and research trends.

Gliomas are the most common form of brain cancer in Australia. Implementing effective early detection and management strategies is essential to improving outcomes and enhancing the quality of life for those affected. This masterclass aims to provide clinicians and trainees with an in-depth, multidisciplinary understanding of current and emerging strategies in the management of low-grade glioma (LGG), with a focus on IDH-mutant gliomas, through expert-led lectures and interactive case-based discussions.

Join local neuro-oncology experts for a review of the latest and most significant international treatment and research findings in brain cancer presented at this year’s Society for Neuro-Oncology Meeting in Houston, Texas. Our expert panel will review the latest in translational science, and clinical updates in low grade glioma and glioblastoma. Drawing on a panel of clinicians and scientist from across Australia, this is a great opportunity to hear their perspectives on how these advances may impact brain cancer care in Australia.